Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors

Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors
Title:
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors
Other Titles:
Nature Communications
Keywords:
Publication Date:
21 November 2016
Citation:
Cheng, H., Ang, H., A. EL Farran, C. et al. Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitors. Nat Commun 7, 13396 (2016). https://doi.org/10.1038/ncomms13396
Abstract:
Recent efforts have attempted to convert non-blood cells into hematopoietic stem cells (HSCs) with the goal of generating blood lineages de novo. Here we show that hematopoietic transcription factors Scl, Lmo2, Runx1 and Bmi1 can convert a developmentally distant lineage (fibroblasts) into ‘induced hematopoietic progenitors’ (iHPs). Functionally, iHPs generate acetylcholinesterase+ megakaryocytes and phagocytic myeloid cells in vitro and can also engraft immunodeficient mice, generating myeloerythoid and B-lymphoid cells for up to 4 months in vivo. Molecularly, iHPs transcriptionally resemble native Kit+ hematopoietic progenitors. Mechanistically, reprogramming factor Lmo2 implements a hematopoietic programme in fibroblasts by rapidly binding to and upregulating the Hhex and Gfi1 genes within days. Moreover the reprogramming transcription factors also require extracellular BMP and MEK signalling to cooperatively effectuate reprogramming. Thus, the transcription factors that orchestrate embryonic hematopoiesis can artificially reconstitute this programme in developmentally distant fibroblasts, converting them into engraftable blood progenitors.
License type:
http://creativecommons.org/licenses/by/4.0/
Funding Info:
The funding number is 1534n00153.
Description:
ISSN:
2041-1723
Files uploaded:

File Size Format Action
ncomms13396.pdf 2.97 MB PDF Open